Friday, October 9, 2015: 8:30 AM-10:00 AM
Room: 6--DE
Learning Objectives:
At the conclusion of this session, participants will be able to:
- identify the status and potential of Staph aureus vaccines on antimicrobial resistance
- review potential opportunities and challenges in successfully developing new vaccines that could combat antimicrobial resistance
Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians
Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID
Moderators:
Andrew Pavia, MD, FIDSA, FSHEA, FPIDS, University of Utah School of Medicine
and
Walter A. Orenstein, MD, FIDSA, FPIDS, Emory University
Presentations:
9:00 AM
Meningococcal Vaccines: A Collision of Illness Burden, Cost-Effectiveness and Public Demand
Jonathan Temte, MD, PhD
Jonathan Temte, MD, PhD
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-169-L04-P
Disclosures:
A. Pavia,
None
See more of: Symposium